DJIA 16,880.36 -31.75 -0.19%
NASDAQ 4,462.90 20.20 0.45%
S&P 500 1,970.07 0.12 0.01%
market minute promo


company name or ticker

Astex Pharmaceuticals, Inc. (ASTX) Management Discusses Q2 2013 Results (Webcast)

BioPharma Catalyst Trade Pick Of The Week: Biodel

Interesting ASTX Put And Call For September 21st

Dr. Reddy's Launches Generic Dacogen - Analyst Blog

Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator

Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator

Astex Pharmaceuticals Could See Significant Short And Long Term Price Appreciation

After Hours Most Active for Jun 21, 2013 : PFE, ZTS$, FHN, SIRI, QLGC, S, MSFT, QCOM, ASTX, INTC, Z

After Hours Most Active for Jun 21, 2013 : PFE, ZTS$, FHN, SIRI, QLGC, S, MSFT, QCOM, ASTX, INTC, ZTS, BAC

MEIP Starts Phase II Study on Pracinostat - Analyst Blog

Data on Astex Candidate - Analyst Blog

Data on Astex Candidate - Analyst Blog

Another Alzheimer's Disease Failure

Eli Lilly stops phase 2 trial of BACE inhibitor after some Alzheimer's patients had abnormal liver biochemical tests.
See More Articles...